semaglutide company Zydus to Launch Day-1 Generic in India With First-of-Its-Kind 15 mg Reusable Multi‑Dose Pen, ETPharma The FDA Has Approved An

Updated September 2, 2025

Key Takeaways: Read also: Nvidia Reportedly in Talks to Back $250B OpenAI Data Center Pfizer keeps expanding its GLP-1 portfolio in China through its second licensing deal in just a few months Ecnoglutide is a once-weekly injection already approved in China, with a weight management application currently under review Competition in the GLP-1 space is heating up fast, with heavyweights like Novo Nordisk and Eli Lilly already leading the pack Ecnoglutide belongs to a class of drugs known as GLP-1 receptor agonists, the same category as Novo Nordisk's Ozempic and Eli Lilly's Mounjaro

Confirmed purity: 99% for FOXO4-DRI D-retro-inverso peptide per COA specification

KLOW Blend Peptide Frequently Asked Questions What is the KLOW blend peptide

Health Canada Drug Product Database - Semaglutide Approved product listings and data-exclusivity timeline (Jan 4, 2026 expiry

Where Can I Get Reconstitution Instructions